News
In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...
1d
24/7 Wall St. on MSN4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return PotentialAfter underperforming the overall market for the past few years, large-cap pharmaceutical stocks may now be positioned to ...
1d
News Nation on MSNRFK Jr. defends vaccine panel overhaul, vows safety testing for all shotsKennedy says the new advisory committee will be free of pharmaceutical conflicts and promises autism studies on childhood vaccines.
While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as ...
5d
Zacks Investment Research on MSNWest Pharmaceutical Services (WST) Surpasses Q2 Earnings and Revenue EstimatesWest Pharmaceutical Services (WST) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.52 per share a year ago ...
Boster Bio pioneers free antibody validation, revolutionizing IHC services with guaranteed reagent reliability, setting new ...
The global market for Pharmaceutical Contract Sales Outsourcing was valued at US$17.3 Billion in 2024 and is projected to reach US$24.8 Billion by 2030, growing at a CAGR of 6.2% from 2024 to 2030 ...
Industry observers, concerned about FIS’s future, questioned whether the Ferrari family, its owner, could continue to run a company that had grown to over 2,000 employees and 300 customers.
Shanghai, China-- (Newsfile Corp. - June 19, 2025) - Frost & Sullivan released the "2025 China Pharmaceutical CDMO Industry Insight Blue Book", a comprehensive analysis of the evolution and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results